# OnCo record jnj-79635322 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/jnj-79635322/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "jnj-79635322" ;
  schema:name "JNJ-79635322"@en ;
  schema:description "JNJ-79635322 is an experimental investigational agent whose form is not stated in the registry from Janssen Research & Development in phase 3 trials for multiple myeloma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/jnj-79635322/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=JNJ-79635322> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "trispecific antibody (BCMA x GPRC5D x CD3, per the sponsor's pipeline page; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:trials <https://onco.cc/trials/nct07258511/>, <https://onco.cc/trials/nct07518186/>, <https://onco.cc/trials/nct07266441/>, <https://onco.cc/trials/nct07589634/> .